Page last updated: 2024-08-21

ethyl pyruvate and Carcinoma, Lewis Lung

ethyl pyruvate has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jung, M; Kim, YJ; Lee, YM; Park, SY; Yi, EY	1

Other Studies

1 other study(ies) available for ethyl pyruvate and Carcinoma, Lewis Lung

Article	Year
Ethyl pyruvate, an anti-inflammatory agent, inhibits tumor angiogenesis through inhibition of the NF-κB signaling pathway. Cancer letters, 2011, Apr-28, Volume: 303, Issue:2 Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Movement; Collagen; Drug Combinations; Endothelial Cells; Humans; Laminin; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; NF-kappa B; Proteoglycans; Pyruvates; Signal Transduction; Vascular Endothelial Growth Factor A; Wound Healing	2011

Article

Year

Ethyl pyruvate, an anti-inflammatory agent, inhibits tumor angiogenesis through inhibition of the NF-κB signaling pathway.

Cancer letters, 2011, Apr-28, Volume: 303, Issue:2

Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Movement; Collagen; Drug Combinations; Endothelial Cells; Humans; Laminin; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; NF-kappa B; Proteoglycans; Pyruvates; Signal Transduction; Vascular Endothelial Growth Factor A; Wound Healing

2011